Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms.

Authors
Type
Published Article
Journal
Journal of Asthma
1532-4303
Publisher
Informa UK (Taylor & Francis)
Publication Date
Volume
45
Issue
9
Pages
754–757
Identifiers
DOI: 10.1080/02770900802249149
PMID: 18972290
Source
Medline
License
Unknown

Abstract

In this study, intranasal BDP was effective in treating rhinitis as well as asthma. The benefits for the lower airways were observed only after prolonged treatment and might be better evaluated through nonspecific bronchial challenge.

Statistics

Seen <100 times